drugset / Trial / NCT05085834
Zinc Effect on Inflammation and Cardiovascular Risk in HIV
Phase 0
Completed
95 enrolled
University Hospitals Cleveland Medical Center
Case Western Reserve University · collabNational Center for Complementary and Integrative Health (NCCIH) · collab
RandomizedParallel-groupQuadruple-blindPrevention
Summary
To study the effect of short-term zinc supplementation on improving inflammation, metabolic, and cardiovascular risk among HIV infected patients on stable anti-retroviral therapy
Timeline
- Start
- 2020-01-22
- Primary completion
- 2024-08-02
- Completion
- 2024-08-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zinc gluconate | Small molecule | 90 mg | Oral |